The Princess of Wales has revealed she’s more conscious about drinking alcohol after her cancer diagnosis, but does she need ...
Lead programme based on a first-in-class small-molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV-positive head and neck cancer Programme has demonstrated strong in ...
Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
Professor Tadashi Yamamoto, head of the Cell Signal Unit at the Okinawa Institute of Science and Technology (OIST), has been ...
Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. Under the leadership of ...
For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...
The Bower Foundation has made the largest single gift in its history, a transformative $10 million investment in It's About Time: The Campaign for the UMMC Cancer Center and Research Institute.
Willowglade Technologies and West Cancer Center & Research Institute Announce Strategic Relationship Focused on ...
Researchers will investigate how a common dietary nutrient may control a hidden layer of gene regulation in cancer cells.